Cargando…
Death risk among COVID-19 patients with diabetes mellitus
Deaths from COVID-19 are increasing in patients with comorbidities. One of the most common comorbidities is diabetes mellitus. The researchers wanted to see how having diabetes affected the mortality rate of COVID-19 participants. This investigation is a case control observational analytical study....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367039/ https://www.ncbi.nlm.nih.gov/pubmed/37497133 http://dx.doi.org/10.4081/jphia.2022.2399 |
_version_ | 1785077302662529024 |
---|---|
author | Dahlia, Dahlia Artanti, Kurnia Dwi Hargono, Arief Martini, Santi Nasr, Nayla Mohamed Gomaa Li, Chung-Yi |
author_facet | Dahlia, Dahlia Artanti, Kurnia Dwi Hargono, Arief Martini, Santi Nasr, Nayla Mohamed Gomaa Li, Chung-Yi |
author_sort | Dahlia, Dahlia |
collection | PubMed |
description | Deaths from COVID-19 are increasing in patients with comorbidities. One of the most common comorbidities is diabetes mellitus. The researchers wanted to see how having diabetes affected the mortality rate of COVID-19 participants. This investigation is a case control observational analytical study. Different types of people, called “cases,” and “controls,” complete the research sample. Each group had 68 responders, for a grand total of 136. Medical records from COVID-19 patients treated at Airlangga University Hospital, Surabaya, between March 2020 and September 2021 serve as the study’s secondary data source. The purpose of this study’s data analysis is to calculate an odds ratio. Patients with COVID-19 with concomitant diabetes mellitus had an increased risk of death, and this risk increased with age, gender, and COVID-19 symptoms. In contrast, education, occupation, and laboratory results were not significantly related to mortality among COVID-19 individuals with concomitant diabetes mellitus (GDA status). The results of this study show that COVID-19 patients with concomitant diabetes mellitus are at a higher risk of death if they are over the age of 65, if they are male, and if they have severe symptoms. |
format | Online Article Text |
id | pubmed-10367039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-103670392023-07-26 Death risk among COVID-19 patients with diabetes mellitus Dahlia, Dahlia Artanti, Kurnia Dwi Hargono, Arief Martini, Santi Nasr, Nayla Mohamed Gomaa Li, Chung-Yi J Public Health Afr Article Deaths from COVID-19 are increasing in patients with comorbidities. One of the most common comorbidities is diabetes mellitus. The researchers wanted to see how having diabetes affected the mortality rate of COVID-19 participants. This investigation is a case control observational analytical study. Different types of people, called “cases,” and “controls,” complete the research sample. Each group had 68 responders, for a grand total of 136. Medical records from COVID-19 patients treated at Airlangga University Hospital, Surabaya, between March 2020 and September 2021 serve as the study’s secondary data source. The purpose of this study’s data analysis is to calculate an odds ratio. Patients with COVID-19 with concomitant diabetes mellitus had an increased risk of death, and this risk increased with age, gender, and COVID-19 symptoms. In contrast, education, occupation, and laboratory results were not significantly related to mortality among COVID-19 individuals with concomitant diabetes mellitus (GDA status). The results of this study show that COVID-19 patients with concomitant diabetes mellitus are at a higher risk of death if they are over the age of 65, if they are male, and if they have severe symptoms. PAGEPress Publications, Pavia, Italy 2022-12-07 /pmc/articles/PMC10367039/ /pubmed/37497133 http://dx.doi.org/10.4081/jphia.2022.2399 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Dahlia, Dahlia Artanti, Kurnia Dwi Hargono, Arief Martini, Santi Nasr, Nayla Mohamed Gomaa Li, Chung-Yi Death risk among COVID-19 patients with diabetes mellitus |
title | Death risk among COVID-19 patients with diabetes mellitus |
title_full | Death risk among COVID-19 patients with diabetes mellitus |
title_fullStr | Death risk among COVID-19 patients with diabetes mellitus |
title_full_unstemmed | Death risk among COVID-19 patients with diabetes mellitus |
title_short | Death risk among COVID-19 patients with diabetes mellitus |
title_sort | death risk among covid-19 patients with diabetes mellitus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367039/ https://www.ncbi.nlm.nih.gov/pubmed/37497133 http://dx.doi.org/10.4081/jphia.2022.2399 |
work_keys_str_mv | AT dahliadahlia deathriskamongcovid19patientswithdiabetesmellitus AT artantikurniadwi deathriskamongcovid19patientswithdiabetesmellitus AT hargonoarief deathriskamongcovid19patientswithdiabetesmellitus AT martinisanti deathriskamongcovid19patientswithdiabetesmellitus AT nasrnaylamohamedgomaa deathriskamongcovid19patientswithdiabetesmellitus AT lichungyi deathriskamongcovid19patientswithdiabetesmellitus |